What Causes ALS? | Research Revealed | TDP-43 Published 2016-11-15 Download video MP4 360p Download video MP4 720p Recommendations 02:32 Potential environmental triggers of sporadic ALS 02:11 What Makes Us Move? Motor Neurons Explained | Lab Life 17:06 What You Need to Know About ALS 01:58 2-Minute Neuroscience: Amyotrophic Lateral Sclerosis (ALS) 19:13 What Causes ALS? with Robert Kalb, MD 07:28 Leah's ALS Story 13:22 Amyotrophic Lateral Sclerosis (ALS) - Diagnosis and Treatment By Dr. B S Rajput - 9820850187 04:04 The UK's First Kennedy's Disease Clinic 10:59 The Brewing FDA Battle Over ALS Treatment 26:25 Susan Lindquist (Whitehead, MIT / HHMI) 1b: Protein Folding in Neurodegenerative Disease 04:02 What are the causes of ALS? 56:11 Lab Med and Pathology Research & Discovery Seminar | Jessica Young PhD 03:34 Living with ALS for decades: The long struggle and complex questions patients face 39:35 Beyond Motor Symptoms of PD - UF Parkinson's Disease Symposium 2023 07:53 TDP43 and Alzheimer's Study 10:21 Race to a cure for ALS 11:02 Why doctors are advising against Benadryl 04:34 Glia: Could These Brain Cells Help Explain What Causes Dementia? 03:27 The Power of Stem Cells Explained | Lab Life 54:44 Deciphering the Molecular Pathology of Alzheimer’s Disease Similar videos 1:01:17 USER TALK: How TDP-43 Condensation Modulates its RNA Processing and How This is Relevant for ALS 01:42 UNC Science Short: How to Battle Protein Clumping in ALS 59:09 R. Baloh - Deciphering the role of TDP-43 in ALS and other neurodegenerative disorders 03:15 TDP-43 and ALS (2018) 06:57 TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD 06:05 Using antibodies and intrabodies to target pathogenic TDP-43 in ALS 24:29 Gregory Petsko (Cornell) 3: Neurodegenerative disease: A potential gene therapy for ALS 43:10 M. Neumann - TDP-43 , FUS and beyond... 01:38 The neuropathology and genetics of ALS and FTD 27:14 "Stathmin-2: An Emerging Therapeutic Target in TDP-43 Proteinopathies" 02:42 TDP-43 in nerve bundles- a novel diagnostic biomarker for Amyotrophic Lateral Sclerosis 16:50 K. Talbot - Physiological models of TDP-43 related amyotrophic lateral sclerosis 16:24 E. Buratti - TDP-43 aggregation, splicing alteration, and neurodegeneration 05:16 Drug-like Molecules Decrease Toxic Protein Clumping in ALS 03:27 TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD 02:44 ALS Research 01:15 An overview of the developments in ALS research More results